Neurological and neuropsychiatric disorders associated with COVID-19. Part I: overview and neurological disorders
Jazyk angličtina, portugalština Země Brazílie Médium electronic-ecollection
Typ dokumentu dopisy
PubMed
34730705
PubMed Central
PMC8528447
DOI
10.31744/einstein_journal/2021ce6448
PII: S1679-45082021000100958
Knihovny.cz E-zdroje
- MeSH
- COVID-19 * MeSH
- lidé MeSH
- nemoci nervového systému * MeSH
- SARS-CoV-2 MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- dopisy MeSH
Department of Rehabilitation Faculty of Medicine University of Ostrava Ostrava Czech Republic
Faculdade de Medicina de Ribeirão Preto Universidade de São Paulo Ribeirão Preto SP Brazil
Faculty of Medicine and Pharmacy Medicine and Surgery Sapienza University of Rome Rome Italy
Zobrazit více v PubMed
1. World Health Organization (WHO). WHO coronavirus disease (COVID-19) dashboard. Geneva: WHO; 2020 [cited 2020 Dec 16] [Last update 2021 Aug 24]. Available from: https://covid19.who.int/
World Health Organization. WHO . WHO coronavirus disease (COVID-19) dashboard. Geneva: WHO; 2020. [cited 2020 Dec 16]. https://covid19.who.int/ Last update 2021 Aug 24.
2. Chen D, Song F, Tang L, Zhang H, Shao J, Qiu R, et al. Quarantine experience of close contacts of COVID-19 patients in China: a qualitative descriptive study. Gen Hosp Psychiatry. 2020;66:81-8. PubMed PMC
Chen D, Song F, Tang L, Zhang H, Shao J, Qiu R, et al. Quarantine experience of close contacts of COVID-19 patients in China: a qualitative descriptive study. Gen Hosp Psychiatry. 2020;66:81–88. PubMed PMC
3. Mazza MG, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I, Melloni EM, Furlan R, Ciceri F, Rovere-Querini P; COVID-19 BioB outpatient clinic study group, Benedetti F. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594-600. PubMed PMC
Mazza MG, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I, Melloni EM, Furlan R, Ciceri F, Rovere-Querini P, COVID-19 BioB outpatient clinic study group. Benedetti F. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594–600. PubMed PMC
4. Fiani B, Covarrubias C, Desai A, Sekhon M, Jarrah R. A contemporary review of neurological sequelae of COVID-19. Front Neurol. 2020;11:640. Review. PubMed PMC
Fiani B, Covarrubias C, Desai A, Sekhon M, Jarrah R. A contemporary review of neurological sequelae of COVID-19. 640Front Neurol. 2020;11 Review. PubMed PMC
5. Ahmad I, Rathore FA. Neurological manifestations and complications of COVID-19: a literature review. J Clin Neurosci. 2020;77:8-12. Review. PubMed PMC
Ahmad I, Rathore FA. Neurological manifestations and complications of COVID-19: a literature review. J Clin Neurosci. 2020;77:8–12. Review. PubMed PMC
6. Gklinos P. Neurological manifestations of COVID-19: a review of what we know so far. J Neurol. 2020;267(9):2485-9. Review. PubMed PMC
Gklinos P. Neurological manifestations of COVID-19: a review of what we know so far. J Neurol. 2020;267(9):2485–2489. Review. PubMed PMC
7. Theoharides TC, Conti P. COVID-19 and multisystem inflammatory syndrome, or is it mast cell activation syndrome? J Biol Regul Homeost Agents. 2020;34(5):1633-6. PubMed
Theoharides TC, Conti P. COVID-19 and multisystem inflammatory syndrome, or is it mast cell activation syndrome? J Biol Regul Homeost Agents. 2020;34(5):1633–1636. PubMed
8. Fan H, Tang X, Song Y, Liu P, Chen Y. Influence of COVID-19 on cerebrovascular disease and its possible mechanism. Neuropsychiatr Dis Treat. 2020;16:1359-67. Review. PubMed PMC
Fan H, Tang X, Song Y, Liu P, Chen Y. Influence of COVID-19 on cerebrovascular disease and its possible mechanism. Neuropsychiatr Dis Treat. 2020;16:1359–1367. Review. PubMed PMC
9. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. Erratum in: Lancet. 2020; 395(10229):1038. PubMed PMC
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. Erratum in: Lancet. 2020; 395(10229):1038. PubMed PMC
10. Connors JM, Levy JH. Thromboinflammation and the hypercoagulability of COVID-19. J Thromb Haemost. 2020;18(7):1559-61. PubMed PMC
Connors JM, Levy JH. Thromboinflammation and the hypercoagulability of COVID-19. J Thromb Haemost. 2020;18(7):1559–1561. PubMed PMC
11. Tovani-Palone MR, Storari L, Barbari V. Could preventing thromboembolism be a new hope for COVID-19 patients? Electron J Gen Med. 2020;17(6):em250.
Tovani-Palone MR, Storari L, Barbari V. Could preventing thromboembolism be a new hope for COVID-19 patients? em250Electron J Gen Med. 2020;17(6)
12. Koralnik IJ, Tyler KL. COVID-19: a global threat to the nervous system. Ann Neurol. 2020;88(1):1-11. Review. PubMed PMC
Koralnik IJ, Tyler KL. COVID-19: a global threat to the nervous system. Ann Neurol. 2020;88(1):1–11. Review. PubMed PMC
13. Berger JR. COVID-19 and the nervous system. J Neurovirol. 2020;26(2):143-8. Review. PubMed PMC
Berger JR. COVID-19 and the nervous system. J Neurovirol. 2020;26(2):143–148. Review. PubMed PMC
14. Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55-8. PubMed PMC
Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55–58. PubMed PMC
15. Zhao K, Huang J, Dai D, Feng Y, Liu L, Nie S. Acute myelitis after SARS-CoV-2 infection: a case report. medRxiv [preprint]. 2020 April 9:2020:20035105; doi: 10.1101/2020.03.16.20035105 [cited 2020 May 30]. Available from: https://www.medrxiv.org/content/10.1101/2020.03.16.20035105v2 DOI
Zhao K, Huang J, Dai D, Feng Y, Liu L, Nie S. [cited 2020 May 30];Acute myelitis after SARS-CoV-2 infection: a case report. medRxiv. 2020 Apr 9;:20035105. doi: 10.1101/2020.03.16.20035105. https://www.medrxiv.org/content/10.1101/2020.03.16.20035105v2 preprint. 2020. DOI
16. Garg RK. Spectrum of neurological manifestations in Covid-19: a review. Neurol India. 2020;68(3):560-72. Review. PubMed
Garg RK. Spectrum of neurological manifestations in Covid-19: a review. Neurol India. 2020;68(3):560–572. Review. PubMed
17. Parma V, Ohla K, Veldhuizen MG, Niv MY, Kelly CE, Bakke AJ, et al. More than smell-COVID-19 is associated with severe impairment of smell, taste, and chemesthesis. Chem Senses. 2020;45(7):609-22. PubMed PMC
Parma V, Ohla K, Veldhuizen MG, Niv MY, Kelly CE, Bakke AJ, et al. More than smell-COVID-19 is associated with severe impairment of smell, taste, and chemesthesis. Chem Senses. 2020;45(7):609–622. PubMed PMC
18. Camdessanche JP, Morel J, Pozzetto B, Paul S, Tholance Y, Botelho-Nevers E. COVID-19 may induce Guillain-Barré syndrome. Rev Neurol (Paris). 2020; 176(6):516-8. PubMed PMC
Camdessanche JP, Morel J, Pozzetto B, Paul S, Tholance Y, Botelho-Nevers E. COVID-19 may induce Guillain-Barré syndrome. Rev Neurol (Paris) 2020;176(6):516–518. PubMed PMC
19. Rahimi K. Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports. Neurol Sci. 2020;41(11):3149-56. Review. Erratum in: Neurol Sci. 2020 Sep 23. PubMed PMC
Rahimi K. Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports. Neurol Sci. 2020;41(11):3149–3156. Review. Erratum in: Neurol Sci. 2020 Sep 23. PubMed PMC
20. Gutiérrez-Ortiz C, Méndez-Guerrero A, Rodrigo-Rey S, San Pedro-Murillo E, Bermejo-Guerrero L, Gordo-Mañas R, et al. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020;95(5):e601-5. PubMed
Gutiérrez-Ortiz C, Méndez-Guerrero A, Rodrigo-Rey S, San Pedro-Murillo E, Bermejo-Guerrero L, Gordo-Mañas R, et al. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020;95(5):e601–e605. PubMed
21. McGonagle D, Sharif K, O’Regan A, Bridgewood C. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev. 2020;19(6):102537. Review. PubMed PMC
McGonagle D, Sharif K, O’Regan A, Bridgewood C. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev. 2020;19(6):102537. Review. PubMed PMC